PortfoliosLab logoPortfoliosLab logo
IBRX vs. VITL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

IBRX vs. VITL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and Vital Farms, Inc. (VITL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

IBRX vs. VITL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
IBRX
ImmunityBio, Inc.
260.61%-22.66%-49.00%-0.99%-16.61%-54.39%19.23%
VITL
Vital Farms, Inc.
-58.05%-15.26%140.22%5.16%-17.39%-28.64%-28.22%

Fundamentals

Market Cap

IBRX:

$7.07B

VITL:

$616.66M

EPS

IBRX:

-$0.37

VITL:

$1.44

PS Ratio

IBRX:

59.34

VITL:

0.81

Total Revenue (TTM)

IBRX:

$113.29M

VITL:

$759.44M

Gross Profit (TTM)

IBRX:

$112.54M

VITL:

$285.68M

EBITDA (TTM)

IBRX:

-$257.20M

VITL:

$88.37M

Returns By Period

In the year-to-date period, IBRX achieves a 260.61% return, which is significantly higher than VITL's -58.05% return.


IBRX

1D
-6.91%
1M
-31.61%
YTD
260.61%
6M
187.90%
1Y
141.22%
3Y*
57.72%
5Y*
-20.44%
10Y*
-1.88%

VITL

1D
-5.10%
1M
-33.40%
YTD
-58.05%
6M
-67.04%
1Y
-56.70%
3Y*
-4.32%
5Y*
-9.41%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRX vs. VITL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX
IBRX Risk / Return Rank: 8282
Overall Rank
IBRX Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
IBRX Sortino Ratio Rank: 8484
Sortino Ratio Rank
IBRX Omega Ratio Rank: 8080
Omega Ratio Rank
IBRX Calmar Ratio Rank: 8686
Calmar Ratio Rank
IBRX Martin Ratio Rank: 7878
Martin Ratio Rank

VITL
VITL Risk / Return Rank: 66
Overall Rank
VITL Sharpe Ratio Rank: 33
Sharpe Ratio Rank
VITL Sortino Ratio Rank: 33
Sortino Ratio Rank
VITL Omega Ratio Rank: 44
Omega Ratio Rank
VITL Calmar Ratio Rank: 1414
Calmar Ratio Rank
VITL Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRX vs. VITL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Vital Farms, Inc. (VITL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBRXVITLDifference

Sharpe ratio

Return per unit of total volatility

1.31

-1.09

+2.39

Sortino ratio

Return per unit of downside risk

2.43

-1.88

+4.31

Omega ratio

Gain probability vs. loss probability

1.29

0.79

+0.51

Calmar ratio

Return relative to maximum drawdown

3.23

-0.75

+3.98

Martin ratio

Return relative to average drawdown

5.28

-1.69

+6.97

IBRX vs. VITL - Sharpe Ratio Comparison

The current IBRX Sharpe Ratio is 1.31, which is higher than the VITL Sharpe Ratio of -1.09. The chart below compares the historical Sharpe Ratios of IBRX and VITL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


IBRXVITLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

-1.09

+2.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.18

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.12

-0.30

+0.18

Correlation

The correlation between IBRX and VITL is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

IBRX vs. VITL - Dividend Comparison

Neither IBRX nor VITL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IBRX vs. VITL - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.14%, which is greater than VITL's maximum drawdown of -80.31%. Use the drawdown chart below to compare losses from any high point for IBRX and VITL.


Loading graphics...

Drawdown Indicators


IBRXVITLDifference

Max Drawdown

Largest peak-to-trough decline

-97.14%

-80.31%

-16.83%

Max Drawdown (1Y)

Largest decline over 1 year

-42.44%

-75.18%

+32.74%

Max Drawdown (5Y)

Largest decline over 5 years

-94.40%

-75.18%

-19.22%

Max Drawdown (10Y)

Largest decline over 10 years

-97.03%

Current Drawdown

Current decline from peak

-83.10%

-74.43%

-8.67%

Average Drawdown

Average peak-to-trough decline

-83.94%

-46.27%

-37.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.97%

33.17%

-7.20%

Volatility

IBRX vs. VITL - Volatility Comparison

ImmunityBio, Inc. (IBRX) has a higher volatility of 38.62% compared to Vital Farms, Inc. (VITL) at 14.31%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than VITL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


IBRXVITLDifference

Volatility (1M)

Calculated over the trailing 1-month period

38.62%

14.31%

+24.31%

Volatility (6M)

Calculated over the trailing 6-month period

88.04%

39.07%

+48.97%

Volatility (1Y)

Calculated over the trailing 1-year period

108.71%

52.31%

+56.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.62%

52.31%

+61.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.61%

52.45%

+59.16%

Financials

IBRX vs. VITL - Financials Comparison

This section allows you to compare key financial metrics between ImmunityBio, Inc. and Vital Farms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
38.29M
213.55M
(IBRX) Total Revenue
(VITL) Total Revenue
Values in USD except per share items